Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled crossover study of GSK2798745 in chronic cough
2017-002265-21Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK2798745 in chronic cough (2 arms), sponsored by GSK. Primary endpoint: Total cough counts during daytime hours after 7 days of dosing. Started Oct 2017; status: completed.
02
Drugs
GSK2798745
03
Conditions
chronic cough
Beyond the preview
Go deeper on 2017-002265-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002265-21.